Use of pharmacokinetic/ pharmacodynamic modelling for starting dose selection in first‐in‐human trials of high‐risk biologics by Agoram, Balaji M.

Get full text

Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development by Agoram, Balaji M., Demin, Oleg

Get full text

The role of mechanism-based pharmacokinetic–pharmacodynamic (PK–PD) modelling in translational research of biologics by Agoram, Balaji M., Martin, Steven W., van der Graaf, Piet H.

Get full text

Mathematical analysis of the pharmacokinetic–pharmacodynamic (PKPD) behaviour of monoclonal antibodies: Predicting in vivo potency by Aston, Philip J., Derks, Gianne, Raji, Adewale, Agoram, Balaji M., van der Graaf, Piet H.

Get full text

A mathematical analysis of rebound in a target-mediated drug disposition model: II. With feedback by Aston, Philip J., Derks, Gianne, Agoram, Balaji M., van der Graaf, Piet H.

Get full text

A mathematical analysis of rebound in a target-mediated drug disposition model: I.Without feedback by Aston, Philip J., Derks, Gianne, Agoram, Balaji M., van der Graaf, Piet H.

Get full text

A non-parametric method to analyse time-course of effect in the absence of pharmacokinetic data: Application to inhaled bronchodilators by Agoram, Balaji M., Milligan, Peter A., van der Graaf, Piet H.

Get full text

Mathematical Analysis of the Pharmacokinetic-Pharmacodynamic (PKPD) Behaviour of Monoclonal Antibodies: Predicting Potency by Aston, Philip J., Derks, Gianne, Raji, Adewale, Agoram, Balaji M., van Der Graaf, Piet H.

Get full text

Predicting the impact of physiological and biochemical processes on oral drug bioavailability by Agoram, Balaji, Woltosz, Walter S., Bolger, Michael B.

Get full text

Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe Asthma by Ly, Neang, Zheng, Yanan, Griffiths, Janet M., Merwe, Rene, Agoram, Balaji, Parnes, Jane R., Roskos, Lorin

Get full text

Effects of IL‐1β–Blocking Therapies in Type 2 Diabetes Mellitus: A Quantitative Systems Pharmacology Modeling Approach to Explore Underlying Mechanisms by Palmér, R, Nyman, E, Penney, M, Marley, A, Cedersund, G, Agoram, B

Get full text

Inhalation by Design: Novel Tertiary Amine Muscarinic M 3 Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary... by Glossop, Paul A., Watson, Christine A. L., Price, David A., Bunnage, Mark E., Middleton, Donald S., Wood, Anthony, James, Kim, Roberts, Dannielle, Strang, Ross S., Yeadon, Michael, Perros-Huguet, Christelle, Clarke, Nicholas P., Trevethick, Michael A., Machin, Ian, Stuart, Emilio F., Evans, Steven M., Harrison, Anthony C., Fairman, David A., Agoram, Balaji, Burrows, Jane L., Feeder, Neil, Fulton, Craig K., Dillon, Barry R., Entwistle, David A., Spence, Fiona J.

Get full text

Inhalation by Design: Novel Tertiary Amine Muscarinic M3 Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary... by Glossop, Paul A, Watson, Christine A. L, Price, David A, Bunnage, Mark E, Middleton, Donald S, Wood, Anthony, James, Kim, Roberts, Dannielle, Strang, Ross S, Yeadon, Michael, Perros-Huguet, Christelle, Clarke, Nicholas P, Trevethick, Michael A, Machin, Ian, Stuart, Emilio F, Evans, Steven M, Harrison, Anthony C, Fairman, David A, Agoram, Balaji, Burrows, Jane L, Feeder, Neil, Fulton, Craig K, Dillon, Barry R, Entwistle, David A, Spence, Fiona J

Get full text